| ?? |
?? ?? |
CAS |
MF |
 |
H-89 DIHYDROCHLORIDE HYDRATE |
130964-39-5 |
C20H20BrN3O2S.2ClH.H2O |
 |
CP 91149 |
186392-40-5 |
C21H21ClN3O3 |
 |
DBeQ |
177355-84-9 |
C22H20N4 |
 |
GW791343 HCl |
309712-55-8 |
C20H27Cl3F2N4O |
 |
PYR 41 |
418805-02-4 |
C17H13N3O7 |
 |
BAM7 |
331244-89-4 |
C21H19N5O2S |
 |
4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide |
58131-57-0 |
C11H13N5O4 |
 |
Erastin |
571203-78-6 |
C30H31ClN4O4 |
 |
GDC-0152 |
873652-48-3 |
C25H34N6O3S |
 |
CGS 21680A |
124431-80-7 |
C23H30ClN7O6 |
 |
Nodinitib-1 |
799264-47-4 |
C14H13N3O2S |
 |
IEM 1754 dihydrobroMide |
162831-31-4 |
C16H32Br2N2 |
 |
NSC697923 |
343351-67-7 |
C11H9NO5S |
 |
Raf265 derivative |
1942849-27-5 |
C23H14F6N6O |
 |
BAF-312(SiponiMod) |
1230487-00-9 |
C29H35F3N2O3 |
![2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide](/CAS/GIF/304896-28-4.gif) |
2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide |
304896-28-4 |
C23H13Cl2N3O2 |
 |
Ferrostatin-1 (Fer-1) |
347174-05-4 |
C15H22N2O2 |
 |
BV6 |
1001600-56-1 |
C70H96N10O8 |
 |
AKT?????? |
842148-40-7 |
C16H19N7O3 |
![L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2)](/CAS/GIF/685898-44-6.gif) |
L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2) |
685898-44-6 |
C13H19Cl3N2O3 |
 |
Cabotegravir (GSK744, GSK1265744) |
1051375-10-0 |
C19H17F2N3O5 |
 |
Verdinexor (KPT-335) |
1392136-43-4 |
C18H12F6N6O |
 |
OG-L002 |
1357302-64-7 |
C15H15NO |
 |
Selinexor |
1393477-72-9 |
C17H11F6N7O |
 |
WAY100635 |
1092679-51-0 |
C29H38N4O6 |
 |
WS3 |
1421227-52-2 |
C28H30F3N7O3 |
 |
Cathepsin Inhibitor 1 |
225120-65-0 |
C20H24ClN5O2 |
 |
Deltarasin |
1440898-61-2 |
C40H37N5O |
 |
GSK-2110183C |
1047644-62-1 |
C18H17Cl2FN4OS |
 |
ReModelin hydrobroMide |
1622921-15-6 |
C15H15BrN4S |
 |
??4 |
838818-26-1 |
C29H23N5O3S |
 |
FTI 277 HYDROCHLORIDE |
180977-34-8 |
C22H30ClN3O3S2 |
 |
PD 151746 |
179461-52-0 |
C11H8FNO2S |
 |
LB 42708 |
226929-39-1 |
C30H27BrN4O2 |
 |
BI-97C1 |
1228108-65-3 |
C42H40N2O8 |
 |
PI-1840 |
1401223-22-0 |
C22H26N4O3 |
 |
SCR7 |
1533426-72-0 |
C18H14N4OS |
 |
CPI-203 |
1446144-04-2 |
C19H18ClN5OS |
 |
HO-3867 |
1172133-28-6 |
C28H30F2N2O2 |
 |
LFM-A13 |
244240-24-2 |
C11H8Br2N2O2 |
 |
GSK1324726A (I-BET726) |
1300031-52-0 |
C25H23ClN2O3 |
 |
PFI3 |
1819363-80-8 |
C19H19N3O2 |
 |
MG149 |
1243583-85-8 |
C22H28O3 |
 |
ARQ 621 |
1095253-39-6 |
C28H24Cl2FN5O2 |
 |
ISRIB (trans-isoMer) |
1597403-47-8 |
C22H24Cl2N2O4 |
 |
Dizocilpine |
77086-21-6 |
C16H15N |
 |
SBE 13 hydrochloride |
1052532-15-6 |
C24H28Cl2N2O4 |
 |
GZD824 |
1421783-64-3 |
C31H35F3N6O7S2 |
 |
YH239-EE |
1364488-67-4 |
C25H27Cl2N3O4 |
 |
Defactinib |
1073154-85-4 |
C20H21F3N8O3S |
 |
Triapine |
200933-27-3 |
C7H9N5S |
 |
K-Ras inhibitor |
1469338-01-9 |
C20H30ClN3O2S3 |
 |
SH-4-54 |
1456632-40-8 |
C29H27F5N2O5S |
 |
GSK-LSD1 |
1431368-48-7 |
C14H20N2 |
 |
RGFP 109 |
1215493-56-3 |
C20H25N3O2 |
 |
BRD4770 |
1374601-40-7 |
C25H23N3O3 |
 |
LDC1267 |
1361030-48-9 |
C30H26F2N4O5 |
 |
EPZ015666 |
1616391-65-1 |
C20H25N5O3 |
 |
HYDROXYGUANIDINE SULFATE |
6345-29-5 |
C2H12N6O6S |
 |
VER-49009 |
940289-57-6 |
C19H18ClN3O4 |
 |
N-(4-Mesitylthiazol-2-yl)benzaMide |
1001753-24-7 |
C19H18N2OS |
 |
LDC000067 |
1073485-20-7 |
C18H18N4O3S |
 |
OF-1 |
919973-83-4 |
C17H18BrN3O4S |
 |
LMK-235 |
1418033-25-6 |
C15H22N2O4 |
 |
BS-181 HCl |
1397219-81-6 |
C22H33ClN6 |
 |
1-(4-(2-((4-chloro-2-hydroxy-5-iodophenyl)aMino)acetyl)piperazin-1-yl)prop-2-en-1-one |
1469337-95-8 |
C15H17ClIN3O3 |
 |
4SC-202(?????) |
910462-43-0 |
C23H21N5O3S |
 |
RGFP966 |
1396841-57-8 |
C21H19FN4O |
 |
K-Ras(G12C) inhibitor 6 |
2060530-16-5 |
C17H22Cl2N2O3S |
 |
SR2516 |
1061353-68-1 |
C25H26F3N5O3 |
 |
Tubastatin-A |
1252003-15-8 |
C20H21N3O2 |
 |
K-Ras(G12C) inhibitor 9 |
1469337-91-4 |
C16H21ClIN3O4S |
![5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide](/CAS/20180629/GIF/1253584-84-7.gif) |
5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide |
1253584-84-7 |
C22H22N4O7 |
 |
MI-3 (Menin-MLL Inhibitor) |
1271738-59-0 |
C18H25N5S2 |
![4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide](/CAS/20150408/GIF/953769-46-5.gif) |
4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide |
953769-46-5 |
C20H22N4O3S |
 |
EW-7197 |
1352608-82-2 |
C22H18FN7 |
 |
LY2409881???? |
946518-60-1 |
C24H30Cl2N6OS |
 |
WHI-P97 |
211555-05-4 |
C16H13Br2N3O3 |
 |
AZD 2932 |
883986-34-3 |
C24H25N5O4 |
 |
PRX-08066 Maleic acid |
866206-55-5 |
C23H21ClFN5O4S |
 |
Cerdulatinib HCl salt |
1369761-01-2 |
C20H28ClN7O3S |
 |
UMI-77 |
518303-20-3 |
C18H14BrNO5S2 |
 |
ZM 39923 HCl |
1021868-92-7 |
C23H26ClNO |
 |
BMX-IN-1 |
1431525-23-3 |
C29H24N4O4S |
 |
PFI-2 |
1627676-59-8 |
C23H25F4N3O3S |
 |
Cyclophosphamide-d4 |
173547-45-0 |
C7H15Cl2N2O2P |
 |
ML 141 |
71203-35-5 |
C22H21N3O3S |
 |
KP372-1 |
329710-24-9 |
C10H4N6O |
 |
CH5138303 |
959763-06-5 |
C19H18ClN5O2S |
 |
CAY10683 (SantacruzaMate A) |
1477949-42-0 |
C15H22N2O3 |
 |
Nafamostat mesylate |
|
|
 |
115007-34-6 |
115007-34-6 |
|
![BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]-](/CAS/20150408/GIF/1186206-79-0.gif) |
BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]- |
1186206-79-0 |
C32H32F3N5O2S |
 |
Olverembatinib |
1257628-77-5 |
C29H27F3N6O |
 |
ME0328 |
1445251-22-8 |
C19H19N3O2 |
 |
HPOB |
1429651-50-2 |
C17H18N2O4 |
 |
BRD73954 |
1440209-96-0 |
C16H16N2O3 |
 |
BIX 01294 |
1392399-03-9 |
C28H41Cl3N6O2 |
![5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine](/CAS/20150408/GIF/1394076-92-6.gif) |
5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine |
1394076-92-6 |
C19H22N6O3S |
 |
LDN-214117 |
1627503-67-6 |
C25H29N3O3 |